| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1600012 | 重组人源化抗肿瘤坏死因子α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2016-05-03 | 深圳万乐药业有限公司 | Shenzhen Main Luck Pharmaceuticals INC | Certificate Issued | 2017-07-06 | view |